The effects of sesame, canola, and sesame-canola oils on cardiometabolic markers in patients with type 2 diabetes: a triple-blind three-way randomized crossover clinical trial
- PMID: 35596008
- DOI: 10.1007/s00394-022-02898-9
The effects of sesame, canola, and sesame-canola oils on cardiometabolic markers in patients with type 2 diabetes: a triple-blind three-way randomized crossover clinical trial
Abstract
Aims: To compare the effects of replacing regular dietary oils intake with sesame (SO), canola (CO), and sesame-canola (SCO) oils (a novel blend), on cardiometabolic markers in adults with type 2 diabetes mellitus (T2DM), in a triple-blind, three-way, randomized, crossover clinical trial.
Methods: Participants were assigned to receive SO, CO, and SCO in three 9-week phases (4 weeks apart). Cardiometabolic makers (serum lipids, Apolipoprotein, cardiovascular risk scores, kidney markers, and blood pressure) were considered at the beginning and the end of intervention phases.
Results: Ninety-two, ninety-five, and ninety-five participants completed the SO, SCO, and CO periods, respectively. After CO consumption, serum Apo A-1 concentrations were significantly higher compared with the SCO period in the whole population (p < 0.05). A considerable reduction in visceral adiposity index values was seen in the CO compared with the SO period in males (p < 0.05). Serum high-density lipoprotein concentration was also significantly higher after the SO intake compared with SCO in females (p < 0.05). The between-period analysis showed a substantial reduction in diastolic blood pressure in the SCO period compared with the CO and SO periods and lower systolic blood pressure after SCO versus CO intake in males (p < 0.05).
Conclusions: Canola oil might protect CVD through improving Apo A-1 levels in patients with T2DM (particularly in females) and visceral adiposity index in male patients. However, the blend oil might beneficially affect blood pressure in men. Future sex-specific studies might warrant the current findings.
Registry of clinical trials: This trial was registered in the Iranian Registry of Clinical Trials (IRCT, registration ID: IRCT2016091312571N6).
Keywords: Apolipoprotein; Canola oil; Cardiovascular risk factors; Dietary oils; Dyslipidemia; Hypertension; Lipids; Lipoproteins; Rapeseed oil; Sesame oil; Type 2 diabetes mellitus.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Similar articles
-
The effect of sesame, canola, and sesame-canola oils on cardiometabolic risk factors in overweight adults: a three-way randomized triple-blind crossover clinical trial.Phytother Res. 2022 Feb;36(2):1043-1057. doi: 10.1002/ptr.7381. Epub 2022 Jan 23. Phytother Res. 2022. PMID: 35066950 Clinical Trial.
-
Effects of sesame, canola and sesame-canola oils on body weight and composition in adults with type 2 diabetes mellitus: a randomized, triple-blind, cross-over clinical trial.J Sci Food Agric. 2021 Nov;101(14):6083-6092. doi: 10.1002/jsfa.11265. Epub 2021 May 26. J Sci Food Agric. 2021. PMID: 33899246 Clinical Trial.
-
Canola oil compared with sesame and sesame-canola oil on glycaemic control and liver function in patients with type 2 diabetes: A three-way randomized triple-blind cross-over trial.Diabetes Metab Res Rev. 2021 Jul;37(5):e3399. doi: 10.1002/dmrr.3399. Epub 2020 Sep 9. Diabetes Metab Res Rev. 2021. PMID: 32860716 Clinical Trial.
-
The effects of Canola oil on cardiovascular risk factors: A systematic review and meta-analysis with dose-response analysis of controlled clinical trials.Nutr Metab Cardiovasc Dis. 2020 Nov 27;30(12):2133-2145. doi: 10.1016/j.numecd.2020.06.007. Epub 2020 Jun 18. Nutr Metab Cardiovasc Dis. 2020. PMID: 33127255
-
Effects of Canola Oil Consumption on Lipid Profile: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.J Am Coll Nutr. 2019 Feb;38(2):185-196. doi: 10.1080/07315724.2018.1475270. Epub 2018 Oct 31. J Am Coll Nutr. 2019. PMID: 30381009
Cited by
-
Cardiometabolic risk factors are affected by interaction between FADS1 rs174556 variant and dietary vegetable oils in patients with diabetes: a randomized controlled trial.Sci Rep. 2024 Nov 11;14(1):27531. doi: 10.1038/s41598-024-78294-6. Sci Rep. 2024. PMID: 39528535 Free PMC article. Clinical Trial.
-
A Comprehensive Review of Health-Benefiting Components in Rapeseed Oil.Nutrients. 2023 Feb 16;15(4):999. doi: 10.3390/nu15040999. Nutrients. 2023. PMID: 36839357 Free PMC article. Review.
-
Effects of canola oil on body weight and composition in adults: an updated systematic review and meta-analysis of 32 randomized controlled trials.Nutr J. 2025 Apr 8;24(1):55. doi: 10.1186/s12937-025-01117-5. Nutr J. 2025. PMID: 40200305 Free PMC article.
-
Ranolazine as a therapeutic agent for diabetic cardiomyopathy: reducing endoplasmic reticulum stress and inflammation in type 2 diabetic rat model.BMC Pharmacol Toxicol. 2025 May 27;26(1):111. doi: 10.1186/s40360-025-00945-9. BMC Pharmacol Toxicol. 2025. PMID: 40426266 Free PMC article.
References
-
- Atlas D (2015) International diabetes federation. IDF Diabetes Atlas, 7th edn Brussels, Belgium: International Diabetes Federation
-
- Acs A, Ludwig C, Bereza B, Einarson T, Panton U (2017) Prevalence of cardiovascular disease in type 2 diabetes: a global systematic review. Value Health 20(9):A475 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials